A photo of Chet Villa.

Pediatric Cardiologist, Heart Failure & Transplantation

Associate Professor, UC Department of Pediatrics



Board Certified

About Me


Children with severe heart disease once had few clinical options. While we’ve made many advances, it’s still critical that we improve therapeutic options and develop new approaches.

At Cincinnati Children’s, I care for children with complex medical needs and severe heart disease. This includes children with Duchenne muscular dystrophy, RASopathies, and those in need of ventricular assist device therapy and heart transplant.

My research is focused on finding ways to provide care to children and young adults with heart disease who have limited access to advanced therapies.

Clinical Interests

Advanced heart failure; heart transplantation; cardiomyopathy; mechanical circulatory support

Research Interests

Ventricular assist device therapy; Duchenne muscular dystrophy

Academic Affiliation

Associate Professor, UC Department of Pediatrics


Cardiomyopathy, Rasopathy, Cardio-Oncology, Neuromuscular Cardiology, Neuromuscular Disorders

Cincinnati Children's Blog

Top 5 Things to Know About the Heart in Duchenne Muscular Dystrophy

BlogHeart Conditions

Top 5 Things to Know About the Heart in Duchenne Muscular Dystrophy

By Chet Villa, MD5/30/2019

My Locations

My Education

MD: University of Cincinnati College of Medicine, Cincinnati, OH, 2007.

Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.

Certification: American Board of Pediatrics, 2010; Pediatric Cardiology, 2014.

My Publications

Investigation of de novo variation in pediatric cardiomyopathy. Parrott, A; Khoury, PR; Shikany, AR; Lorts, A; Villa, CR; Miller, EM. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. 2020; 184:116-123.

Expanding the donor pool for congenital heart disease transplant candidates by implementing 3D imaging-derived total cardiac volumes. Shugh, SB; Szugye, NA; Zafar, F; Riggs, KW; Villa, C; Lorts, A; Morales, DL S; Moore, RA. Pediatric Transplantation. 2020; 24.

Destination-Therapy Ventricular Assist Device in Children: “The Future Is Now”. Tunuguntla, H; Conway, J; Villa, C; Rapoport, A; Jeewa, A. Canadian Journal of Cardiology. 2020; 36:216-222.

Cost-utility of continuous-flow ventricular assist devices as bridge to transplant in pediatrics. Evers, PD; Villa, C; Wittekind, SG; Hobing, R; Morales, DL S; Lorts, A. Pediatric Transplantation. 2019; 23.

Profound Iron Deficiency Anemia and Irreversible Dilated Cardiomyopathy in a Child. Wittekind, SG; Martinez, HR; Villa, C; Bacon, M; Hammill, AM; Lorts, A. Case Reports in Cardiology. 2019; 2019:7513782-4.

How small can you go? A 2.5-kg infant with pulmonary atresia and coronary atresia bridged to cardiac transplantation with a paracorporeal-continuous flow ventricular assist device. Villa, CR; Lorts, A; Riggs, KW; Alten, J; Morales, DL. Journal of Thoracic and Cardiovascular Surgery. 2019; 158:e67-e69.

Cardiomyopathies. Villa, CR; Jefferies, JL. In: Wernovsky G; Anderson RH; Krishna K; Mussato KA; Redington A; Tweddell JS; Tretter J, Ed. Anderson's Pediatric Cardiology. Philadelphia, PA: Elsevier; 2019.

First Use of HeartMate 3 in a Failing Fontan Circulation. Lorts, A; Villa, C; Riggs, KW; Broderick, J; Morales, DL S. Annals of Thoracic Surgery. 2018; 106:e233-e234.

The Right Tool for the Right Job: Bridging a Failing Fontan to Transplant. Riggs, KW; Lorts, A; Villa, CR; Tweddell, J; III, BR; Morales, DL S. Annals of Thoracic Surgery. 2018; 106:e145-e146.

Transplant Outcomes for Congenital Heart Disease Patients Bridged With a Ventricular Assist Device. III, BR; Rizwan, R; Villa, CR; Zafar, F; Wells, D; Chin, C; Lorts, A; Morales, DL. Annals of Thoracic Surgery. 2018; 106:588-594.